| Friday, July 22 |
| < Opening comments > |
| 9:00 - 9:15 | Tadashi Yamamoto (IMSUT) |
| |
| < Genome medicine > |
| Chair: Yusaku Nakabeppu (MIB, Kyushu U) |
| 9:15 - 9:45 | Yoichi Furukawa (IMSUT) |
| "SMYD3 encodes a novel histone methyltransferase involved in human carcinogenesis." |
| 9:45 - 10:15 | David R. Cox (Perlegen Sci., USA) |
| "Common Human DNA Variation and Personalized Medicine" |
| |
| Coffee break |
| |
| < Molecular modulators of viruses and immune cells > |
| Chair: Jun-ichiro Inoue (IMSUT) |
| 10:30 - 11:00 | Kunitada Shimotohno (IVR, Kyoto U) |
| "Modulation of replication of the HCV genome by cyclophilin B,
a cellular chaperon protein with PPIase" |
| 11:00 - 11:30 | Jean-Louis Virelizier (Pasteur, France) |
| "Chemokine receptors: from basic to clinical approaches" |
| 11:30 - 12:00 | Seishi Murakami (CRI., Kanazawa U) |
| "Transcriptional modulation of Hepatitis B Virus X protein (HBx)
and its roles in HBV replication and in transformation of human cells" |
| |
| Lunch |
| |
| < Putting RNAs to work: the Natural and the Artificial > |
| Chair: Koichi Ito (IMSUT) |
| 13:30 - 14:00 | Yoshikazu Nakamura (IMSUT) |
| "RNA Super-Antibody" |
| 14:00 - 14:30 | Gideon Dreyfuss (Penn U, USA) |
| "The Survival of Motor Neurons (SMN) PROTEIN: Architect of RNPs" |
| |
| Coffee break |
| |
| < Fathoming Complexity: Computational Systems Medicine >
|
| Chair: Kenta Nakai (IMSUT) |
| 14:45 - 15:15 | Satoru Miyano (IMSUT) |
| "Computational Challenges in Systems Biology" |
| 15:15 - 15:45 | John N. Weinstein (NIH, USA) |
| "A Systems Approach to Cancer Drug Discovery:
Integrating Genomics, Proteomics, and Bioinformatics" |
| |
| Coffee break |
| |
| Chair: Robert F. Whittier (IMSUT) |
| 16:00 - 17:30 | Student oral poster presentations (12 X 7 min) |
| 18:00 - 19:30 | Poster viewing with wine & cheese buffet |
| |
|
| |
| Saturday, July 23 |
| < Control of stem cell renewal and differentiation > |
| Chair: Yoichi Shinkai (IVR, Kyoto U) |
| 9:30 - 10:00 | Hiromitsu Nakauchi (IMSUT) |
| "Epigenetic regulation of stem cell self-renewal by Polycomb group protein, Bmi-1" |
| 10:00 - 10:30 | Renee A. Reijo Pera (UCSF, USA) |
| "Differentiation of human germ cells from embryonic stem cells" |
| |
| Coffee break |
| |
| < Signaling, Inflammation and Cancer I > |
| Chair: Katsuji Yoshioka (CRI, Kanazawa U) |
| 10:45 - 11:15 | Hiroaki Miki (IMSUT) |
| "Nucleoredoxin, a Thioredoxin-related redox-regulating protein
inhibits Wnt/beta-catenin signaling through Dishevelled" |
| 11:15 - 11:45 | William J. Muller (McGill U., Canada) |
| "Targeted disruption of ErbB-2 and beta-1 integrin mammary epithelium.
Implications for Human Breast Cancer" |
| 11:45 - 12:15 | Lisa Coussens (UCSF, USA) |
| "Immune Cells as Targets for Cancer Prevention" |
| |
| Lunch |
| |
| < Proteomics: the Meat of Systems Medicine > |
| Chair: Kazuaki Yoshikawa (IPR, Osaka U) |
| 13:45 - 14:15 | Toshifumi Takao (IPR, Osaka U) |
| "Peptide profiling of human urine for biomarker discovery" |
| 14:15 - 14:45 | Koichi Tanaka (Shimadzu Corporation) |
| "Analysis of Post Translational Modification using MALDI-MSn" |
| 14:45 - 15:15 | Zihe Rao (CAS, China) |
| "SARS structural proteomics" |
| |
| Coffee break |
| |
| Chair: Robert F. Whittier (IMSUT) |
| 15:30 - 17:00 | Student oral poster presentation (12 x 7 min) |
| 17:30 - 19:30 | Poster viewing with wine & cheese buffet |
| |
|
| |
| Sunday, July 24 |
| < Signaling, Inflammation and Cancer II > |
| Chair: Hitoshi Kikutani (RIMD, Osaka U) |
| 9:30 - 10:00 | Chikao Morimoto (IMSUT) |
| "The development of humanized anti-CD26 antibody therapy for immune-mediated disorders" |
| 10:00-10:30 | Akihiko Yoshimura (MIB, Kyushu U) |
| "SOCS genes: central regulators of cytokine signaling, inflammation-related carcinogenesis,
and homeostasis" |
| |
| Coffee break |
| |
| < Signaling, Inflammation and Cancer III > |
| Chair: Motoharu Seiki (IMSUT) |
| 10:45 - 11:15 | Hiroshi Nojima (RIMD, Osaka U) |
| "Oleamide derivatives potently block the spontaneous metastasis of cancer cells" |
| 11:15 - 12:00 | Axel Ullrich (IMCB, Singapore) |
| "Oncogenomic strategies towards the development of novel cancer therapies" |
| |
| < Poster awards and closing comments > |
| 12:00 - 12:20 | Motoharu Seiki (IMSUT) |
